FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer
| Autor: | Oliveira, M. *, Saura, C., Nuciforo, P., Calvo, I., Andersen, J., Passos-Coelho, J.L., Gil Gil, M., Bermejo, B., Patt, D.A., Ciruelos, E., de la Peña, L., Xu, N., Wongchenko, M., Shi, Z., Singel, S.M., Isakoff, S.J. |
|---|---|
| Zdroj: | In Annals of Oncology August 2019 30(8):1289-1297 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|